Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 897

1.

Donepezil: an update.

Seltzer B.

Expert Opin Pharmacother. 2007 May;8(7):1011-23. Review.

PMID:
17472546
2.

Donepezil for Alzheimer's disease.

Benjamin B, Burns A.

Expert Rev Neurother. 2007 Oct;7(10):1243-9. Review.

PMID:
17939763
3.

Donepezil: a review.

Seltzer B.

Expert Opin Drug Metab Toxicol. 2005 Oct;1(3):527-36. Review.

PMID:
16863459
4.

The pharmacology of donepezil: a new treatment of Alzheimer's disease.

Wilkinson DG.

Expert Opin Pharmacother. 1999 Nov;1(1):121-35. Review.

PMID:
11249555
5.

Clinical benefits of a new piperidine-class AChE inhibitor.

Doody RS.

Eur Neuropsychopharmacol. 1999 Apr;9 Suppl 2:S69-77. Review.

PMID:
10332937
6.

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study.

Prasher VP, Huxley A, Haque MS; Down syndrome Ageing Study Group.

Int J Geriatr Psychiatry. 2002 Mar;17(3):270-8.

PMID:
11921156
7.

[Medical treatment of Alzheimer's disease].

Johannsen P.

Ugeskr Laeger. 2006 Oct 2;168(40):3424-9. Review. Danish.

PMID:
17032609
8.

[Acetylcholinesterase inhibitors for dementia--an update].

Anghelescu I, Heuser I.

MMW Fortschr Med. 2007 May 21;149 Suppl 2:76-8. Review. German.

PMID:
17724973
9.

Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles.

Shigeta M, Homma A.

CNS Drug Rev. 2001 Winter;7(4):353-68. Review.

10.

Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.

Touchon J, Bergman H, Bullock R, Rapatz G, Nagel J, Lane R.

Curr Med Res Opin. 2006 Jan;22(1):49-59. Erratum in: Curr Med Res Opin. 2006 Aug;22(8):1451.

PMID:
16393430
11.

Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.

Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Takase T, Ohbayashi T.

Dement Geriatr Cogn Disord. 2009;27(3):232-9. doi: 10.1159/000203887. Epub 2009 Feb 25.

PMID:
19246907
12.

Donepezil hydrochloride: a treatment drug for Alzheimer's disease.

Sugimoto H.

Chem Rec. 2001;1(1):63-73. Review.

PMID:
11893059
13.

A 10-year perspective on donepezil.

Cheewakriengkrai L, Gauthier S.

Expert Opin Pharmacother. 2013 Feb;14(3):331-8. doi: 10.1517/14656566.2013.760543. Epub 2013 Jan 14. Review.

PMID:
23316713
14.

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.

Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM; Donepezil MSAD Study Investigators Group.

Int J Geriatr Psychiatry. 2005 Jun;20(6):559-69.

PMID:
15920715
15.

Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.

Rogers SL.

Dement Geriatr Cogn Disord. 1998;9 Suppl 3:29-42. Review.

PMID:
9853200
16.

Donepezil in the treatment of patients with Alzheimer's disease.

Tsuno N.

Expert Rev Neurother. 2009 May;9(5):591-8. doi: 10.1586/ern.09.23. Review.

PMID:
19402770
17.

Clinical profile of donepezil in the treatment of Alzheimer's disease.

Doody RS.

Gerontology. 1999;45 Suppl 1:23-32. Review.

PMID:
9876215
18.

Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.

Boada-Rovira M, Brodaty H, Cras P, Baloyannis S, Emre M, Zhang R, Bahra R; 322 Study Group.

Drugs Aging. 2004;21(1):43-53.

PMID:
14715043
19.

Brain injury, cognitive impairment, and donepezil.

Whitlock JA Jr.

J Head Trauma Rehabil. 1999 Aug;14(4):424-7. No abstract available.

PMID:
10407214
20.

Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.

Passmore AP, Bayer AJ, Steinhagen-Thiessen E.

J Neurol Sci. 2005 Mar 15;229-230:141-6. Epub 2005 Jan 6.

PMID:
15760632

Supplemental Content

Support Center